Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in Moderately Active Rheumatoid Arthritis
NCT01313208Phase 4Completed
- Sponsor
- Amgen
- Start
- Mar 2011
- Primary completion
- Feb 2013
- Modality
- Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 4 trial of etanercept in rheumatoid arthritis (RA), sponsored by Amgen. Started Mar 2011; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01313208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01313208.